Capital Performance Advisors’s KalVista Pharmaceuticals KALV Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-3,845	Closed	-$1.8M	–	298
2025 Q1	$1.8M	Buy	+3,845	New	+$1.8M	0.4%	40